BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for...
BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.38 | -17.9876796715 | 24.35 | 25.75 | 18.33 | 481883 | 20.12568001 | CS |
4 | -2.37 | -10.6087735004 | 22.34 | 27.7 | 18.33 | 403658 | 23.61505277 | CS |
12 | -6.28 | -23.9238095238 | 26.25 | 27.7 | 18.33 | 473919 | 23.57633578 | CS |
26 | -6.28 | -23.9238095238 | 26.25 | 27.7 | 18.33 | 473919 | 23.57633578 | CS |
52 | -6.28 | -23.9238095238 | 26.25 | 27.7 | 18.33 | 473919 | 23.57633578 | CS |
156 | -6.28 | -23.9238095238 | 26.25 | 27.7 | 18.33 | 473919 | 23.57633578 | CS |
260 | -6.28 | -23.9238095238 | 26.25 | 27.7 | 18.33 | 473919 | 23.57633578 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.